189 related articles for article (PubMed ID: 28583673)
21. Artificial cell factory design for shikimate production in Escherichia coli.
Lee HN; Seo SY; Kim HJ; Park JH; Park E; Choi SS; Lee SJ; Kim ES
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34227672
[TBL] [Abstract][Full Text] [Related]
22. Constructing E. coli Co-Cultures for De Novo Biosynthesis of Natural Product Acacetin.
Wang X; Shao A; Li Z; Policarpio L; Zhang H
Biotechnol J; 2020 Sep; 15(9):e2000131. PubMed ID: 32573941
[TBL] [Abstract][Full Text] [Related]
23. Establishing biosynthetic pathway for the production of p-hydroxyacetophenone and its glucoside in Escherichia coli.
Lu L; Wang X; Zhou L; Liu Q; Zhang G; Xue B; Hu C; Shen X; Sun X; Yan Y; Wang J; Yuan Q
Metab Eng; 2023 Mar; 76():110-119. PubMed ID: 36746296
[TBL] [Abstract][Full Text] [Related]
24. Design and construction of an artificial pathway for biosynthesis of acetaminophen in Escherichia coli.
Shen X; Chen X; Wang J; Sun X; Dong S; Li Y; Yan Y; Wang J; Yuan Q
Metab Eng; 2021 Nov; 68():26-33. PubMed ID: 34487838
[TBL] [Abstract][Full Text] [Related]
25. Coordinated Expression of Astaxanthin Biosynthesis Genes for Improved Astaxanthin Production in
Gong Z; Wang H; Tang J; Bi C; Li Q; Zhang X
J Agric Food Chem; 2020 Dec; 68(50):14917-14927. PubMed ID: 33289384
[TBL] [Abstract][Full Text] [Related]
26. Metabolic Engineering of
Hou Y; Liu X; Li S; Zhang X; Yu S; Zhao GR
J Agric Food Chem; 2020 Aug; 68(31):8370-8380. PubMed ID: 32627549
[TBL] [Abstract][Full Text] [Related]
27. Multilevel metabolic engineering of Bacillus licheniformis for de novo biosynthesis of 2-phenylethanol.
Zhan Y; Shi J; Xiao Y; Zhou F; Wang H; Xu H; Li Z; Yang S; Cai D; Chen S
Metab Eng; 2022 Mar; 70():43-54. PubMed ID: 35038552
[TBL] [Abstract][Full Text] [Related]
28. Establishment of Novel Biosynthetic Pathways for the Production of Salicyl Alcohol and Gentisyl Alcohol in Engineered Escherichia coli.
Shen X; Wang J; Gall BK; Ferreira EM; Yuan Q; Yan Y
ACS Synth Biol; 2018 Apr; 7(4):1012-1017. PubMed ID: 29570271
[TBL] [Abstract][Full Text] [Related]
29. Chemical and Biocatalytic Routes to Arbutin
Zhou H; Zhao J; Li A; Reetz MT
Molecules; 2019 Sep; 24(18):. PubMed ID: 31514332
[TBL] [Abstract][Full Text] [Related]
30. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
[TBL] [Abstract][Full Text] [Related]
31. Efficient Production of Chlorogenic Acid in
Wang L; Wang H; Chen J; Hu M; Shan X; Zhou J
J Agric Food Chem; 2023 Oct; 71(41):15204-15212. PubMed ID: 37788431
[TBL] [Abstract][Full Text] [Related]
32. Metabolic engineering of Escherichia coli for production of salvianic acid A via an artificial biosynthetic pathway.
Yao YF; Wang CS; Qiao J; Zhao GR
Metab Eng; 2013 Sep; 19():79-87. PubMed ID: 23774671
[TBL] [Abstract][Full Text] [Related]
33. Efficient Whole-Cell Biotransformation for α-Arbutin Production through the Engineering of Sucrose Phosphorylase Combined with Engineered Cell Modification.
Ao J; Pan X; Wang Q; Zhang H; Ren K; Jiang A; Zhang X; Rao Z
J Agric Food Chem; 2023 Feb; 71(5):2438-2445. PubMed ID: 36701314
[TBL] [Abstract][Full Text] [Related]
34. Precursor-directed biosynthesis of 5-hydroxytryptophan using metabolically engineered E. coli.
Sun X; Lin Y; Yuan Q; Yan Y
ACS Synth Biol; 2015 May; 4(5):554-8. PubMed ID: 25275944
[TBL] [Abstract][Full Text] [Related]
35. Establishing a novel biosynthetic pathway for the production of 3,4-dihydroxybutyric acid from xylose in Escherichia coli.
Wang J; Shen X; Jain R; Wang J; Yuan Q; Yan Y
Metab Eng; 2017 May; 41():39-45. PubMed ID: 28342964
[TBL] [Abstract][Full Text] [Related]
36. Recent progress on biological production of α-arbutin.
Zhu X; Tian Y; Zhang W; Zhang T; Guang C; Mu W
Appl Microbiol Biotechnol; 2018 Oct; 102(19):8145-8152. PubMed ID: 30032433
[TBL] [Abstract][Full Text] [Related]
37. Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of L-DOPA from D-glucose.
Fordjour E; Adipah FK; Zhou S; Du G; Zhou J
Microb Cell Fact; 2019 Apr; 18(1):74. PubMed ID: 31023316
[TBL] [Abstract][Full Text] [Related]
38. Caffeic acid production from glucose using metabolically engineered Escherichia coli.
Sakae K; Nonaka D; Kishida M; Hirata Y; Fujiwara R; Kondo A; Noda S; Tanaka T
Enzyme Microb Technol; 2023 Mar; 164():110193. PubMed ID: 36621069
[TBL] [Abstract][Full Text] [Related]
39. Establishing an Artificial Pathway for De Novo Biosynthesis of Vanillyl Alcohol in Escherichia coli.
Chen Z; Shen X; Wang J; Wang J; Zhang R; Rey JF; Yuan Q; Yan Y
ACS Synth Biol; 2017 Sep; 6(9):1784-1792. PubMed ID: 28586214
[TBL] [Abstract][Full Text] [Related]
40. Optimization of hydrogenobyrinic acid biosynthesis in Escherichia coli using multi-level metabolic engineering strategies.
Jiang P; Fang H; Zhao J; Dong H; Jin Z; Zhang D
Microb Cell Fact; 2020 Jun; 19(1):118. PubMed ID: 32487216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
